Non-adherence to anti- diabetic therapy and its consequences among type-2 diabetic patients in a tertiary care hospital

Authors

  • Veeresh J. Department of Pharmacology, Raichur Institute of Medical Sciences, Raichur, Karnataka, India
  • Vasanth R. Chavan Department of Pharmacology, Raichur Institute of Medical Sciences, Raichur, Karnataka, India
  • Mohammad Arshad Department of Pharmacology, Raichur Institute of Medical Sciences, Raichur, Karnataka, India
  • Raghunandan M. Department of Pharmacology, Raichur Institute of Medical Sciences, Raichur, Karnataka, India
  • Mohd. Fayazuddin Department of Pharmacology, Raichur Institute of Medical Sciences, Raichur, Karnataka, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20172038

Keywords:

Glycemic control, Non-adherence, Type 2 diabetes

Abstract

Background: Despite the extensive therapy options available for various stages of type 2 diabetes, studies have indicated that less than 50% of patients achieve the glycemic goals. Failure to attain the desired therapeutic goal might be related to inadequate adherence. Objectives of present study were to determine the extent of non-adherence to antidiabetic medications and identify reasons for the same.

Methods: A cross-sectional, observational, questionnaire-based study was conducted to assess the level of non-adherence to antidiabetic therapy among type 2 diabetics attending medicine outpatient department or admitted to the wards of a tertiary care hospital from Jan 2015 to Jan 2016. A pretested and validated questionnaire was used to assess the level of adherence. Reasons for missing medications were also elicited. Data thus collected was analysed using a suitable statistical software.

Results: Out of the 210 study participants, 55.2% were females. Most participants were in the age group of 51-60. The mean duration of diabetes was 8.17± 5.39. The most common diabetes-related complication was Diabetic Keto Acidosis (DKA), followed by diabetic foot ulcer. The average number of drugs per prescription was 1.98 ± 1.05. Poor glycemic control was observed in 58% and non-adherence to treatment in 45.2% of study participants.

Conclusions: Good adherence to antidiabetic therapy is fundamental for good glycemic control which in turn prevents the occurrence of short and long-term complications of diabetes. Poor doctor-patient intercommunication and inadequacy on part of physicians to adjust medications negatively affect adherence. Active participation of the patient is also equally important.

References

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diab Care. 2009;32(Suppl 1):S62-S67.

Ogurtsova K, Linnenkamp U, Guariguata L, Whiting D, Shaw J, da Rocha Fernandes JD, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017 Mar 31;128:40-50.

Wild S, Roglic G, Green A, Sicree R, King H. Global Prevalence of Diabetes Estimates for the year 2000 and projections for 2030. Diab Care. 2004;27(5):1047-53.

Gupta M, Singh R, Lehl SS. Diabetes in India: a long way to go. Int J Sci Rep. 2015 May;1(1):1-2.

Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes. 2008 Apr;26(2):77-82.

García-Pérez L-E, Álvarez M, Dilla T, Gil-Guillén V, Orozco-Beltrán D. Adherence to therapies in patients with type 2 diabetes. Diabetes Ther. 2013Aug;4(2):175-94.

Sabaté E. World Health Organization, editors. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003;198:3,7,20,42.

Morisky DE, Ang A, Krousel-Wood M, Ward H. Predictive validity of a medication adherence measure for hypertension control. J Clini Hypert. 2008;10(5):348-54.

Krousel-Wood MA, Islam T, Webber LS, Re RS, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care. 2009;15(1):59-66.

Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication nonadherence: Final response. J Clin Epidemiol. 2011;64:258-63.

Bailey CJ, Kodack M. Patient adherence to medication requirements for therapy of type 2 diabetes. Int J Clin Pract. 2011;65:314-22.

Sharma T, Kalra J, Dhasmana DC et al. Poor adherence to treatment: A major challenge in diabetes. JIACM. 2014;15(1): 26‐9.

Wabe NT, Angamo MT, Hussein S. Medication adherence in diabetes mellitus and self-management practices among type-2 diabetics in Ethiopia. N Am J Med Sci. 2011;3(9):418-23

Nagpal J, Bhartia A. Quality of Diabetes Care in the Middle- and High-Income Group Populace: The Delhi Diabetes Community (DEDICOM) survey. Diab Care. 2006;29(11):2341-8.

Medi RK, Mateti UV, Kanduri KR, Konda SS. Medication adherence and determinants of non-adherence among south Indian diabetes patients. J Soc Health Diab. 2015;3(1):48.

Arulmozhi S, Mahalakshmy T. Self Care and medication adherence among type 2 diabetics in puducherry, southern india: a hospital based study. JCDR. 2014 Apr;8(4):UC01.

Divya S, Nadig P. Factors contributing to non-adherence to medication among type 2 diabetes mellitus in patients attending tertiary care hospital in south India. Asian J Pharmaceu Clini Res. 2015;8(2):274-76.

Downloads

Published

2017-05-23

How to Cite

J., V., Chavan, V. R., Arshad, M., M., R., & Fayazuddin, M. (2017). Non-adherence to anti- diabetic therapy and its consequences among type-2 diabetic patients in a tertiary care hospital. International Journal of Basic & Clinical Pharmacology, 6(6), 1348–1351. https://doi.org/10.18203/2319-2003.ijbcp20172038

Issue

Section

Original Research Articles